An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis

BACKGROUND: Biologic agents are currently the strongest immunosuppressive drugs able to induce remission in rheumatoid arthritis (RA). One of the objectives of the medical scientific community now is how to maintain remission or low disease activity (LDA). The aim of this trial is to evaluate the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Martin, LS, Giovannangeli, F, Bizzi, E, Massafra, U, Ballanti, E, Cassol, M, Migliore, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384731/
https://www.ncbi.nlm.nih.gov/pubmed/28408798
http://dx.doi.org/10.2147/DDDT.S118298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384731/
https://www.ncbi.nlm.nih.gov/pubmed/28408798
http://dx.doi.org/10.2147/DDDT.S118298

Ejemplares similares